Targeting mitochondrial one-carbon enzyme MTHFD2 together with pemetrexed confers therapeutic advantages in lung adenocarcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting mitochondrial one-carbon enzyme MTHFD2 together with pemetrexed confers therapeutic advantages in lung adenocarcinoma
Authors
Keywords
-
Journal
Cell Death Discovery
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-05
DOI
10.1038/s41420-022-01098-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dynamic EMT: a multi‐tool for tumor progression
- (2021) Simone Brabletz et al. EMBO JOURNAL
- MTHFD2 promotes tumorigenesis and metastasis in lung adenocarcinoma by regulating AKT/GSK‐3β/β‐catenin signalling
- (2021) Yangfeng Shi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage
- (2021) Gen Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolic reprogramming and cancer progression
- (2020) Brandon Faubert et al. SCIENCE
- PKMYT1 as a Potential Target to Improve the Radiosensitivity of Lung Adenocarcinoma
- (2020) Huan-ping Long et al. Frontiers in Genetics
- More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?
- (2020) Zhiyuan Zhu et al. Frontiers in Oncology
- FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p)
- (2020) Keiko Mizuno et al. Cells
- Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy
- (2020) Chengcan Yang et al. DRUG DISCOVERY TODAY
- Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases
- (2019) Gan-Guan Wei et al. PATHOLOGY RESEARCH AND PRACTICE
- MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma
- (2019) Nathanael H. Green et al. ONCOGENE
- The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
- (2019) David A. Schaer et al. CLINICAL CANCER RESEARCH
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Down‐regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle‐related genes
- (2019) Chang Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Efficacy and safety of first line treatments for patients with advanced epidermal growth factor receptor mutated, non-small cell lung cancer: systematic review and network meta-analysis
- (2019) Yi Zhao et al. BMJ-British Medical Journal
- The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis
- (2019) Maryam Moradi Binabaj et al. GENE
- Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2
- (2018) Tatsunori Nishimura et al. ONCOGENE
- Spectrum of Lung Adenocarcinoma
- (2018) Barry D. Hutchinson et al. SEMINARS IN ULTRASOUND CT AND MRI
- Long-Term, Supplemental, One-Carbon Metabolism–Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort
- (2017) Theodore M. Brasky et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Metabolic reprogramming in clear cell renal cell carcinoma
- (2017) Hiromi I. Wettersten et al. Nature Reviews Nephrology
- Methylenetetrahydrofolate dehydrogenase 2 overexpression is associated with tumor aggressiveness and poor prognosis in hepatocellular carcinoma
- (2016) Xincheng Liu et al. DIGESTIVE AND LIVER DISEASE
- Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells
- (2015) Mathew C. Casimiro et al. CANCER RESEARCH
- Metabolic Reprogramming of Immune Cells in Cancer Progression
- (2015) Subhra K. Biswas IMMUNITY
- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2015) Gregory A. Masters et al. JOURNAL OF CLINICAL ONCOLOGY
- Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin
- (2015) Matthew G Oser et al. LANCET ONCOLOGY
- The folate-coupled enzyme MTHFD2 is a nuclear protein and promotes cell proliferation
- (2015) Nina Gustafsson Sheppard et al. Scientific Reports
- Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
- (2014) Roland Nilsson et al. Nature Communications
- Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer
- (2010) Junko Kikuchi et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started